2026-01-18 - Analysis Report
**Salesforce Inc (CRM) Analysis:**

**Company Overview**
Salesforce is a global cloud-based customer relationship management (CRM) company.

**Return Rate Comparison**
- Cumulative return of review stock: -19.85%
- Cumulative return of comparison stock (S&P 500, VOO): 93.36%
- Divergence: -111.10 (relative divergence: 0.00%)

### Alpha, Beta Analysis

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
|------|------|------|-------|------|-------|
| 2016-2018 | 21.0% | 29.8% | 17.0% | 1.4 | 130.4B |
| 2017-2019 | 15.0% | 29.8% | -2.0% | 1.4 | 154.8B |
| 2018-2020 | 9.0% | 29.8% | -11.0% | 1.1 | 211.8B |
| 2019-2021 | 33.0% | 21.2% | -10.0% | 1.1 | 241.9B |
| 2020-2022 | -73.0% | 59.8% | -71.0% | 1.2 | 126.2B |
| 2021-2023 | -42.0% | 59.8% | -43.0% | 1.4 | 250.5B |
| 2022-2024 | -37.0% | 52.3% | -56.0% | 1.4 | 318.3B |
| 2023-2025 | 10.0% | 32.1% | -52.0% | 1.2 | 252.2B |

### Recent Stock Price Fluctuations
- 5-day SMA: $240.13
- 20-day SMA: $256.71
- 60-day SMA: $250.08
- Recent market fluctuation: Down 2.75% to $227.11 from $233.53

### RSI, PPO index indicators and Delta_Previous_Relative_Divergence

- Market Risk Indicator (MRI): 0.80
- RSI: 19.68
- PPO: -1.75
- Recent (20 days) relative divergence change: -6.40 (worsening)
- 7-day Rank change: -99 (rank down)
- 7-day Dynamic Expected Return change: -4151.20 (worsening)
- Expected Return (%): -4980.60%

### Recent News & Significant Events
- No concrete news provided in the prompt, however several links were shown:
  * Salesforce.com (CRM) Stock Dips While Market Gains: Key Facts 
  * Reassessing Salesforce (CRM) Valuation After Recent Share Price Weakness And AI Profitability Push 
  * Salesforce: Why CRM Stock Is Undervalued At $240? 
  * Salesforce: Cheap 14x FCF Multiple And Agentforce Acceleration (NYSE:CRM) 
  * The reality check everyoneâ€™s ignoring 
  * Salesforce stock has imploded: Is it a bargain or a value trap?

### Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.64 (~Buy)
- Opinions: 53
- Target Price (avg/high/low): 329.65 / 475.00 / 223.00
```

### Recent Earnings Analysis
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-12-04 | 2.2 | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.6 | 9.44 B$ |


### Financial Information

#### Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $10.26B | 78.02% |
| 2025-07-31 | $10.24B | 78.10% |
| 2025-04-30 | $9.83B | 76.96% |
| 2025-01-31 | $9.99B | 77.81% |
| 2024-10-31 | $9.44B | 77.71% |

#### Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $60.02B | 3.48% |
| 2025-07-31 | $61.33B | 3.08% |
| 2025-04-30 | $60.67B | 2.54% |
| 2025-01-31 | $61.17B | 2.79% |
| 2024-10-31 | $58.52B | 2.61% |

### Comprehensive Analysis

Based on the provided data, Salesforce Inc (CRM) has seen a significant decline in its stock price and performance in recent years. The cumulative return of the review stock is at -19.85%, while the comparison stock (S&P 500, VOO) has seen a return of 93.36%. The divergence is at -111.10, indicating a significant difference in performance between the two stocks.

The Alpha, Beta analysis shows a declining trend in the company's performance, with a significant reduction in its alpha and beta values in the recent years.

The recent stock price fluctuations show a decline in the company's stock price, with a 5-day SMA of $240.13, 20-day SMA of $256.71, and 60-day SMA of $250.08. The recent market fluctuation has seen a down of 2.75% to $227.11 from $233.53.

The RSI, PPO index indicators and Delta_Previous_Relative_Divergence show a bearish trend, with an RSI of 19.68, PPO of -1.75, and recent (20 days) relative divergence change of -6.40.

The recent news and significant events do not provide any concrete evidence to support the current performance of the company.

The Analyst Opinions provide a buy recommendation with a mean target price of 329.65, which is not consistent with the current performance of the company.

Finally, the recent earnings analysis and financial information show a decline in the company's revenue and profitability, with a significant reduction in its profit margin and ROE.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.